RxDoctor Payments Data

Gerardo Baldassarri, MD

Family Medicine · Ponte Vedra, FLNPI 1275504581

Payments from drug & device makers

$1,199in general payments, 2019–2025

Across 49 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$224
  • Lilly USA, LLC$149
  • GSK$128
  • Amgen$113
  • Novo Nordisk$105
  • Dexcom, Inc.$90
  • plus $390 from 11 others

What the payments were for

  • Food & beverage$1,199100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,199 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$156,466
Medicare patients
503
Services billed
2,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$116,984
JardianceEmpagliflozin70$71,061
JanuviaSitagliptin Phosphate55$57,584
MyrbetriqMirabegron38$32,539
RexultiBrexpiprazole28$31,592
XareltoRivaroxaban34$29,622
OzempicSemaglutide27$25,969
LinzessLinaclotide38$25,350
TrulicityDulaglutide22$25,268
JanumetSitagliptin Phos/Metformin Hcl14$19,018
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,479
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$8,995
GemtesaVibegron17$7,965
Rosuvastatin Calcium353$4,432
Levothyroxine Sodium434$4,080

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$76$116,984113 claims
MerckJanuvia, Janumet$18$76,60269 claims
Otsuka America Pharmaceutical, Inc.Rexulti$224$31,59228 claims
Johnson & JohnsonXarelto$22$29,62234 claims
AbbVieLinzess, Synthroid$21$28,99079 claims
Novo NordiskOzempic$105$25,96927 claims
Lilly USA, LLCTrulicity$149$25,26822 claims
GSKTrelegy Ellipta$128$10,47915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Ponte Vedra

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →